January 6, 2017
The drug is indicated to treat or prevent bronchospasm in adults, adolescents and children 6 years of age and older with reversible obstructive airway disease. 
January 4, 2017

Sandoz‘s generic will be available in 40-, 80- and 125-mg dosage strengths.

January 3, 2017

The Food and Drug Administration approved three generics from New Jersey-based specialty generics company Teligent on the last day of 2016, the company announced Tuesday.

January 3, 2017

Lupin in the last week of 2016 received tentative approval for its generics of Benicar tablets, Giazo tablets and Livalo tablets. 

January 3, 2017

The company on Thursday announced the launch of its generics of Concerta extended-release tablets, Zovia tablets and Cerebyx injection. 

December 21, 2016

Walgreens has expanded the availability of prescription-free naloxone to 33 states and the District of Columbia.

December 16, 2016

Carrying a wholesale acquisition cost of $300 per injection, it will reach pharmacies in a week.

December 15, 2016

The drug’s availability comes a year after the Food and Drug Administration approved it as a follow-on biologic to Lantus, another U-100 long-acting insulin. It has an amino acid sequence identical to that of Lantus. 

December 12, 2016

Alvogen and Natco Pharma on Monday announced the launch of their generic of Tamiflu (oseltamivir phosphate) capsules, the first generic of the flu treatment to hit the U.S. market. The generic was approved by the Food and Drug Administration in August.

December 12, 2016
Par’s generic is entitled to market exclusivity based on the first-to-file status of the application filed by its licensing partners, Glenmark Pharmaceuticals USA. 
December 7, 2016

President Obama said in his Dec. 3 weekly address that he would sign the legislation into law "as soon as it reaches my desk."

December 7, 2016

In an interview with Time published Tuesday morning to accompany his being chosen as the magazine’s “Person of the Year,” President-elect Donald Trump told the magazine that one of his goals as president is lowering the cost of prescription drugs.  

December 7, 2016

The drug had U.S. sales of about $75 million for the 12-month period ended October 2016. 

December 6, 2016

Aurobindo’s generic will be available in 20- and 40-mg dosage strengths. 

December 6, 2016

The drug had about $42 million in U.S. sales for the 12 months ended Oct. 31, 2016, according to QuintilesIMS data. 

December 6, 2016
The drug had U.S. sales of $14.4 million for the 12 months ended September 2016. 
 
December 5, 2016
The drug had $119 million in sales for the 12 months ended October 2016, according to QuintilesIMS data.
December 2, 2016

In recognition of World Aids Day on Dec. 1, Aurobindo Pharma shared its continued commitment to doing its part to help fight HIV/AIDS. 

December 1, 2016

Hetero is one of India’s leading generic pharmaceutical companies and is the world’s largest global producer of ARVs for the treatment of HIV/AIDS.

November 30, 2016
The approval is the company’s sixth in its internally developed pipeline of generics.
November 30, 2016

The Rxight test provides information on medications covering 14 therapeutic classes, including pain, blood pressure, blood thinner, ADHD, anxiety, depression, diabetes, cancer, respiratory issues and other medications.

November 29, 2016

The generic was approved by the Food and Drug Administration in September. 

November 29, 2016

The drug is indicated to improve wakefulness in adults with excessive sleepiness associated with obstructive sleep apnea, narcolepsy or shift work disorder. 

November 29, 2016

GPhA president and CEO Chip Davis called for passage of the 21st Century Cures Act, which is headed to the House of Representatives this week, citing its funding for an act that would work to address the prescription drug abuse epidemic.